About IQVIA United Kingdom

Here in the UK, we serve top pharmaceutical companies and the majority of NHS Trusts, being firmly centered between healthcare and life sciences. What differentiates us is Institutional Knowledge, gained from being the UK’s leading clinical trial provider through partnerships with the NHS in three ‘prime sites’ covering a population of around 13 million people, and from our 250 London based Real-World Evidence experts. Our Advanced Technology platforms and capabilities allow us to provide real-time access to operations critical information for our customers. We have Unparalleled Data¸ with over 1 billion anonymised patient transactions every year. And finally, Advanced Analytics that underpin faster more precise decision-making, giving actionable insights into patient care and medicines usage. It is these CORE capabilities and our partnerships with the NHS and life sciences that are the catalyst to truly advance UK healthcare.

Motivated by the industry we help, we’re committed to providing solutions that enable life sciences companies to innovate with confidence, maximize opportunities, and, ultimately, drive human health outcomes forward.

Learn more

NHS Solutions
Fueling transformation to increase value and improve patient outcomes
Real-World Evidence in Oncology
A new IQVIA report shows how the UK is leading the way in the use of real-world patient data in oncology to improve patient outcomes, and how it influences treatment pathways, reimbursement decision, and clinical development. 
Finding a Cure
Getting the Best Brexit Deal for Britain’s Life Sciences.
​The Next Evolution of Biologics
Disruption and maturity: the next evolution of biologics white paper.